These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36692658)

  • 61. Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.
    Yang P; Wang C; Ye Y; Huang T; Yang S; Shen W; Xu G; Wu Q
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):371-381. PubMed ID: 32232617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Chiang CE; Liao JN; Chen TJ; Lip GYH; Chen SA
    Chest; 2020 May; 157(5):1266-1277. PubMed ID: 31809694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
    Sherwood MW; Piccini JP; Holmes DN; Pieper KS; Steinberg BA; Fonarow GC; Allen LA; Naccarelli GV; Kowey PR; Gersh BJ; Mahaffey KW; Singer DE; Ansell JE; Freeman JV; Chan PS; Reiffel JA; Blanco R; Peterson ED; Rao SV
    Circ Cardiovasc Interv; 2020 May; 13(5):e008274. PubMed ID: 32408815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
    Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    Lee HJ; Kim HK; Kim BS; Han KD; Park JB; Lee H; Lee SP; Kim YJ
    PLoS One; 2021; 16(6):e0253310. PubMed ID: 34138972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.
    Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
    JAMA Cardiol; 2017 Aug; 2(8):872-881. PubMed ID: 28614582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis.
    Dawwas GK; Barnes GD; Dietrich E; Cuker A; Leonard CE; Genuardi MV; Lewis JD
    Am Heart J; 2021 Dec; 242():71-81. PubMed ID: 34450051
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases.
    Lip GYH; Keshishian A; Kang A; Luo X; Atreja N; Zhang Y; Schuler P; Jiang J; Yuce H; Deitelzweig S
    J Thromb Thrombolysis; 2022 Jul; 54(1):33-46. PubMed ID: 35579733
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study.
    Wang CL; Wu VC; Huang YT; Kuo CF; Chu PH; Chen YL; Wen MS; Chang SH
    J Am Heart Assoc; 2019 May; 8(9):e012029. PubMed ID: 31020896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study.
    Paciaroni M; Agnelli G; Falocci N; Tsivgoulis G; Vadikolias K; Liantinioti C; Chondrogianni M; Bovi P; Carletti M; Cappellari M; Zedde M; Ntaios G; Karagkiozi E; Athanasakis G; Makaritsis K; Silvestrelli G; Lanari A; Ciccone A; Putaala J; Tomppo L; Tatlisumak T; Abdul-Rahim AH; Lees KR; Alberti A; Venti M; Acciarresi M; D'Amore C; Becattini C; Mosconi MG; Cimini LA; Soloperto R; Masotti L; Vannucchi V; Lorenzini G; Tassi R; Guideri F; Acampa M; Martini G; Sohn SI; Marcheselli S; Mumoli N; De Lodovici ML; Bono G; Furie KL; Tadi P; Yaghi S; Toni D; Letteri F; Tassinari T; Kargiotis O; Lotti EM; Flomin Y; Mancuso M; Maccarrone M; Giannini N; Bandini F; Pezzini A; Poli L; Padovani A; Scoditti U; Denti L; Consoli D; Galati F; Sacco S; Carolei A; Tiseo C; Gourbali V; Orlandi G; Giuntini M; Chiti A; Giorli E; Gialdini G; Corea F; Ageno W; Bellesini M; Colombo G; Monaco S; Maimone Baronello M; Karapanayiotides T; Caso V
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29220330
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 74. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis.
    Bang OY; On YK; Lee MY; Jang SW; Han S; Han S; Won MM; Park YJ; Lee JM; Choi HY; Kang S; Suh HS; Kim YH
    PLoS One; 2020; 15(11):e0242922. PubMed ID: 33253294
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.
    Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Chest; 2019 Feb; 155(2):354-363. PubMed ID: 30472021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
    Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.
    Loo SY; Coulombe J; Dell'Aniello S; Brophy JM; Suissa S; Renoux C
    BMJ Open; 2018 Jan; 8(1):e019638. PubMed ID: 29371284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.